Microvast Holdings, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 16, 2026 (21 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| Apr 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Apr 3, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $3 | 44% |
| Apr 2, 2024 | Janney Montgomery Scott | downgrade | Buy → Neutral | $3 | 55% |
| Apr 2, 2024 | Oppenheimer | maintain | Outperform → Outperform | $4 | 52% |
| Dec 13, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $8 | 50% |
| Nov 29, 2023 | Cantor Fitzgerald | initiate | — → Overweight | $8 | 50% |
| Aug 31, 2023 | Janney Montgomery Scott | initiate | — → Buy | $8 | 55% |
| Aug 8, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $8 | 52% |
| May 26, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $8 | 52% |
| May 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Apr 3, 2023 | HC Wainwright & Co. | initiate | — → Buy | $8 | 44% |
| Mar 17, 2023 | Oppenheimer | reiterate | — → Outperform | $8 | 52% |
| Aug 19, 2022 | Oppenheimer | initiate | — → Outperform | $8 | 52% |
| Apr 1, 2022 | Morgan Stanley | maintain | — → Underweight | $4 | 54% |
| Dec 17, 2021 | Piper Sandler | initiate | — → Neutral | $8 | 54% |
| Aug 4, 2021 | Morgan Stanley | initiate | — → Underweight | $6 | 54% |
No cross-platform signals in the last 90 days